Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
The GRPR Antagonist [99mTc]Tc-maSSS-PEG2-RM26 towards Phase I Clinical Trial: Kit Preparation, Characterization and Toxicity.
Diagnostics (Basel). 2023 May 2;13(9):1611. doi: 10.3390/diagnostics13091611.
Diagnostics (Basel). 2023.
PMID: 37175001
Free PMC article.
Phase I Trial of [99mTc]Tc-maSSS-PEG2-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors.
Chernov V, Rybina A, Zelchan R, Medvedeva A, Bragina O, Lushnikova N, Doroshenko A, Usynin E, Tashireva L, Vtorushin S, Abouzayed A, Rinne SS, Sörensen J, Tolmachev V, Orlova A.
Chernov V, et al. Among authors: rybina a.
Cancers (Basel). 2023 Mar 7;15(6):1631. doi: 10.3390/cancers15061631.
Cancers (Basel). 2023.
PMID: 36980517
Free PMC article.
Item in Clipboard
Cite
Cite